News

Shares of Livongo Health (NASDAQ: LVGO) soared on Tuesday, jumping about 20%. The stock's gain came after the company gave investors an early glimpse into its recently ended second quarter. Revenue

With Warren Buffett's Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) weighing in at the end of the first quarter with an all-time record $137 billion in cash, cash equivalents, and marketable

Tough times create big problems for many companies, and inevitably, there are casualties when unexpected financial turmoil hits. With the COVID-19 pandemic, Hertz Global Holdings (NYSE: HTZ) proved

Spotify (NYSE: SPOT) shares have soared following a string of podcasting deals. But not everyone's as sold on the streaming specialist's strategy as the rest of the market. 

Bernstein analyst Todd

When investors consider which companies belong in their portfolios, a stock's price per share should not be a primary factor. A small price tag has little real bearing on whether a stock is actually

Payment processing giant Visa (NYSE: V) has grown into a mega cap stock in just a little over a decade as a publicly traded company, with a market capitalization of about $420 billion as of this

Veeva Systems (NYSE: VEEV) stock gained 66.7% in the first half of 2020 (January through June), according to data from S&P Global Market Intelligence. The S&P 500 returned negative 3.1% over this

The COVID-19 pandemic may have slowed down the rollout of 5G (fifth generation) wireless networks, but the long-term opportunity remains intact. A third-party report says that 5G infrastructure

There's a lot of debate right now over whether to grant Americans a second stimulus check to follow the first round of payments that went out starting in April. But that's not the only relief

The biotech industry has been red-hot lately, especially among those companies that are frantically searching for products to help in the fight against the COVID-19 pandemic. Shares of Inovio

A safe and effective vaccine would be a shot in the arm for a world that's grown weary of the COVID-19 pandemic. The good news is that there's a lot of work going on to produce just such a vaccine

While the market has recovered sharply since the March lows, it's important for investors to realize that we're not out of the woods just yet. COVID-19 cases are spiking in several key areas of the

A COVID-19 vaccine will be worth billions and billions of dollars. It will likely be the most valuable drug on the planet. There are many pharmaceutical companies are pursuing a vaccine, and the

Retail cannabis sales in Canada have rebounded from a brief dip in February, but Organigram (NASDAQ: OGI) stock hasn't followed. Shares of the licensed cannabis producer have lost about 30% of their

2020 has been a rough year for many stock investors. For those who've concentrated on the Nasdaq 100 index of top stocks trading on the Nasdaq Stock Market, though, returns have been strong. As of

Coronavirus vaccines have been making headlines recently, but so far, they all remain merely candidates in various stages of development. Nearly 130 investigational vaccines are in preclinical

When is the best time to claim Social Security retirement benefits? This is a hot topic among financial experts and pre-retirees. Claiming benefits early could reduce them by as much as 30%, while

What a time it is to be an investor. Years from now, we'll be starting our stories with the words, "Back in 2020..." and we'll instantly remember how volatile things were at the time due to the

These days, investing is something I do regularly. I like to joke that when friends and I talk about going shopping, they're referring to clothing and shoes while I'm referring to stocks.

But that

I'm a picky investor. I buy only the highest-quality growth stocks I can find.

I look for companies that are rapidly improving their financial statements, boast a strong competitive position, have a

This year has truly been a tale of two markets. For a five-week period in the first quarter, downside momentum in the stock market tied to the coronavirus disease 2019 (COVID-19) pandemic was unlike

In this episode of Industry Focus: Energy, Nick Sciple chats with Bethany McLean, contributing editor at Vanity Fair and financial journalist widely known for writing on the Enron scandal and the

Shares of Clorox (NYSE: CLX) surged by 42.9% in the first six months of 2020, according to data from S&P Global Market Intelligence.

The stock got a big boost this year from the COVID-19 pandemic

Shares of inverter manufacturer Enphase Energy (NASDAQ: ENPH) fell 18.3% in June, according to data from S&P Global Market Intelligence after a short-seller report questioned the company's

Shares of CoStar Group (NASDAQ: CSGP) tacked on 19% through the first six months of the year, according to data from S&P Global Market Intelligence, as the data-driven real estate business was able